Reckitt Benckiser Group (OTCMKTS:RBGLY) Sets New 52-Week High - Still a Buy?

Key Points

• Reckitt Benckiser Group hit a new 52-week high at $15.83 following a trading volume of 11,967 shares, an increase from its previous close of $15.57.
• The company maintains a majority of positive ratings, with two analysts issuing a Strong Buy and two a Buy rating, resulting in an overall average rating of "Buy".
• Reckitt Benckiser recently announced a dividend of $0.2106, representing a significant yield of 341.0%, but this comes after a recent cut in dividends.

Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) reached a new 52-week high on Friday . The stock traded as high as $15.83 and last traded at $15.83, with a volume of 11967 shares trading hands. The stock had previously closed at $15.57.

Analyst Ratings Changes

Separately, Royal Bank Of Canada reissued an "outperform" rating on shares of Reckitt Benckiser Group in a research report on Friday, July 25th. Two analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of "Buy".

Reckitt Benckiser Group Stock Up 1.6%

The company has a current ratio of 0.56, a quick ratio of 0.37 and a debt-to-equity ratio of 1.01. The firm has a 50-day simple moving average of $15.24 and a two-hundred day simple moving average of $14.14.

Reckitt Benckiser Group Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Thursday, September 25th. Stockholders of record on Monday, August 11th were given a $0.2106 dividend. The ex-dividend date of this dividend was Friday, August 8th. This represents a dividend yield of 341.0%.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.